Prompted by the occurrence in our department of a case of an MTVS that conformed fully to Cahan's criteria for radiation-induced tumors, 7 we conducted a literature search to identify other cases and compiled a list significantly larger than previous reviews.
Case Report
A 46-year-old woman with no evidence of NF2 presented with impaired hearing in 2003, and in mid-2004 underwent subtotal resection of a right-sided vestibular schwannoma (VS). The histological characteristics of the tumor were benign. Postoperatively, the patient exhibited a House-Brackmann Grade IV facial paresis and had no residual hearing on the right side.
In 2007 a residual enlarging tumor remnant was noted on MR imaging and GKS was performed. The radiosurgery parameters at the time included the following: target volume 3.5 cm 3 , prescription dose 12 Gy, prescription isodose 45%, maximum dose 26.7 Gy, coverage 97%, Paddick Conformity Index 0.8, and Gradient Index 3.0. At the 2-year follow-up in 2009, MR imaging showed that the lesion had enlarged to 5.2 cm 3 , but by 2012 it had decreased to 2.3 cm 3 . Six months later, an MR imaging examination showed that the lesion had grown rapidly to 8.4 cm 3 . Repeated partial excision was performed, and a new histological analysis revealed a malignant peripheral nerve sheath tumor (MPNST) with MIB-1 positivity in 30% of the cells. Immunohistochemical analysis of the tumor cells showed a general positive reaction for vimentin and a focal positive reaction for S-100 protein, but negative reactions for CD56, CD34, EMA, and GFAP. The delay in onset from radiosurgical treatment to presentation of malignant transformation totaled 66 months.
In the spring of 2013 the surgical remnant was treated again with GKS. The radiosurgery parameters at that time were as follows: target volume 3.5 cm 3 , prescription dose 16 Gy, prescription isodose 45%, maximum dose 35.6 Gy, coverage 91%, Paddick Conformity Index 0.7, and Gradient Index 2.8. In 2014, at the patient's 6-month follow-up examination, no change in the tumor was found, and no new cranial nerve or other neurological deficit had developed.
A literature search was performed using the terms malignant, transformation, radiosurgery, vestibular, acoustic, schwannoma, neuroma, and malignant peripheral nerve sheath tumor/MPNST on PubMed together with a search and cross-check using Google Scholar. In addition, detailed contents of the publications retrieved in the search were cross-checked, because in some instances the same cases were reported in more than one journal by different authors.
Results
A total of 59 cases of MPNST of the vestibular nerve were reported in the literature: 29 cases occurred after radiation treatment, 25 cases arose spontaneously, and 5 cases occurred after surgery for benign disease. The details of these cases are summarized in Tables 1-3 . The two largest collected series reported previously included 23 cases 57 and 35 cases. 32 Of the 29 cases of MPNST that occurred after radiation treatment, 11 (40.7%) of 26 patients in whom there was available information suffered from NF (Table 1 ). The average patient age was 40.4 years; 14 patients were female, 10 were male, and gender was not stated for the remaining 5 patients. The histological appearance of the tumor was MPNST in 19 patients, triton tumor in 3 patients, rhabdomyosarcoma in 1 patient, and MPNST with sarcomatous differentiation in 4 patients. In 2 cases the histological type of lesion was not clarified, but the progression was clearly malignant. Twenty-six cases had been treated by stereotactic radiosurgery (SRS) and 3 others by other forms of radiation therapy. In only 9 cases had histology proved the tumor benign before radiation treatment was performed. In the other cases there was no biopsy or the histological findings were not recorded. The overall mean delay from radiation treatment to malignant expression was 85 months. In those cases with documented prior benign histological findings that totally conformed to Cahan's criteria, 7 the mean delay from radiation treatment to malignant expression was 68 months. The criteria for malignant transformation, as originally outlined by Cahan et al., 7 are as follows: 1) benign histological type must be proven before irradiation; 2) there must be a prolonged latency period, usually greater than 4 years, between radiation delivery and tumor development; 3) the tumor must arise in the irradiated field; 4) the tumor must be histologically distinct from the original tumor; and 5) the patient must not have a genetic predisposition to the development of cancer.
Of the 30 cases that occurred without previous radiation treatment, 5 (17%) of 29 patients suffered from NF (Tables 2 and 3 ). Thirteen patients were female, 14 were male, and sex was not stated for 3 patients. The average age of these patients was 43.2 years in the 25 patients in whom malignancy occurred spontaneously and 59 years in the 5 cases of MTVS. The histological tumor appearance was MPNST in 23 patients, triton tumor in 4 patients, and MPNST with melanomatous differentiation in 3 patients. In 4 cases the histological findings had proved to be benign at some time before the malignant condition appeared, and in these cases the mean delay to malignant expression was 7.2 months.
The chronology of published reports on the various cases was analyzed by dates of publication, and the results are shown in Table 4 . It is evident that the incidence of cases in the three 5-year periods beginning in the year 2000 (43 cases) is approximately 3 times greater than the incidence of cases in the three 5-year periods before 2000 (15 cases). The millennium year, 2000, occurred 10 years after significant numbers of radiosurgical treatments for VS began to be performed.
Discussion
The case that we have described represents the 9th reported case of MTVS after radiation treatment that conforms fully to Cahan's criteria and the 29th case of MPNST occurring after radiotherapy or radiosurgery.
The topic most in need of evaluation is the determi-nation of the significance of radiation in the induction of malignancy, which up to now has not been quantified precisely. With reported numbers of malignant VSs in the radiation-treated population being the same as the numbers of malignant VSs in the immensely larger, non-radiation-treated population, the effect of radiation is clear. However, there may be a relative tendency to report cases involving previous radiation treatment more frequently. It is inevitable that the conclusions of this paper depend on the accuracy and comprehensiveness of reporting. The population incidence of VS has been calculated to be between 12 and 19 per million people per year.
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Assuming an even prevalence and an average world population of 6 billion between 1990 and 2014, the number of VSs that develop globally per year would range from 72,000 to 114,000. In relation to the number of cases that have been reported, the chance of developing a spontane- . In cases of VS treated by radiation the risk needs to be related to the total population treated. According to Leksell Gamma Knife Society (LGKS) reports, 33 the total number of GKSs for VS reported worldwide between 1991 and 2012 was 70,353. A survey by the Acoustic Neuroma Association in 2012 showed that 39% of radiation treatments were fractionated and 61% were single fraction. 1 If one postulates that the proportion of singlefraction treatments represents GKSs and the remaining treatments were delivered by other methods, and if one assumes that the ratio in the United States applies to the rest of the world, then the total number of patients with VS treated by radiation worldwide could be around . If patients with NF are excluded from this analysis, there remain 18 patients whose MPNST was associated with radiation treatment, and thus the risk for malignant transformation in the absence of NF is accordingly 15.6 × 10 . This represents a 9 to 14 times increased probability of malignancy in relation to that spontaneous incidence of between 1.09 × 10 -5 and 1.74 × 10
. An independent study in patients with NF revealed that in a population of 1348 patients with NF2, 106 would have received radiosurgery. 5 Malignant transformation occurred in 5 of these cases. This corresponds to a risk of
, a substantially greater risk than that found in patients who do not have NF. We found a greater proportion of patients with NF in the group of patients treated with radiation, which is compatible with the increased susceptibility of NF cases to radiation.
There are certain other prominent differences between cases treated with radiation and cases not treated in this manner. The first is the delay or latency from diagnosis to malignant expression. In cases in which radiation was delivered, this is 68 months (in cases of initial benign disease confirmed by histology) or 85 months (in all cases) compared with 7.2 months in cases in which there was no radiation treatment and there was a prior histological diagnosis of benign disease. This would suggest that the cases involving radiation treatment are showing the delay required by the Cahan criteria for malignant induction, whereas the cases without radiation treatment are already in the process of malignant expression. Table 1 shows that 2 cases involving radiation treatment 20, 25 had an insignificant delay, 6 months for 1 case and 7 months for the other, and therefore may not be cases of true malignant transformation due to radiation, even though one of these patients 20 had histologically defined benign disease before SRS.
In addition, the group of patients with previous radiation treatment contains a larger proportion of cases in which histology revealed a sarcomatous element (8 [29. 6%] of 27 cases) than the group with no previous radiation treatment (4 [13.3%] of 30 cases). Sarcomatous differentiation is known to be associated with irradiation, and the overall incidence of post-irradiation sarcoma in patients who survive longer than 5 years following radiation therapy is approximately 0.1%. 27 This pattern of sarcomatous change also suggests that the malignant progression is due to radiation, although it is appropriate to point out that the rate of malignancy after radiosurgery for VS is 10 times less than that expected after radiation treatment of peripheral bone or soft tissue. 27 Finally, there is evidence from the chronology of publications ( Table 4) that there has been a 3-fold increase in case reports since the year 2000. If a delay period of 5 to 8 years, according to Cahan's criteria, is added to the decade of 1990, when significant numbers of radiosurgical treatments began to be performed, then an increase in reported cases of MTVS would be expected from 2000 onwards if radiation is a significant predisposing factor for malignant progression. As has been noted earlier, there may be a tendency to report MTVSs more readily than spontaneous malignant VSs. It could also be argued that the armamentarium and expertise of neuropathologists has improved together with a general explosion in the number of published medical papers. Nevertheless, the sudden change in the reported numbers of MTVSs after the year 2000 seems significant.
Although the available information clearly indicates that there is a real chance of malignant transformation due to SRS, both the medical community and patients should be reassured that the risk is very low. The calculations above enumerate the risk value as 15.6 × 10 -5 or 0.016% in the absence of NF. This compares favorably with a realistic mortality rate after craniotomy of between 1% and 2%. 9, 49 Although there are a few smaller surgical series of selected cases in which there were no deaths, 52 it is not realistic to expect a surgical series of 10,000 cases without some mortality, and this is the number of cases required for a comparative result.
Conclusions
Despite more frequent reports of MTVS after radiation therapy, there has been no previous accurate quantification of the risk, except in cases of NF in which the incidence of malignancy is high in relation to the numbers treated. The present review indicates that the risk of malignancy over 20 years in cases in which no radiation was used is 1.32-2.08 per 100,000, and this decreases to 1.09-1.74 per 100,000 if cases of NF are excluded. The analysis of published cases reveals that after radiation treatment the overall risk over 20 years is 25.1 per 100,000, and this decreases to 15.6 per 100,000 if cases of NF are excluded. Radiation treatment therefore increases the risk by approximately 10 times in non-NF cases. 
